Showing results (1081-1090 of 1,186) with videos related to

Sort By:
Pageof 119
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|January 10, 2019
Cognitive Behavioral Therapy for Insomnia Reduces Depression in Cancer SurvivorsAnita R Peoples, Sheila N Garland, Wilfred R Pigeon, et al.
Parkinsonism & Related Disorders|August 19, 2015
Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine releaseMattia Volta, Stefano Cataldi, Dayne Beccano-Kelly, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 24, 2019
Second nationwide anti-tuberculosis drug resistance survey in NamibiaN Ruswa, F Mavhunga, J C Roscoe, et al.
Cancer Research|February 5, 2008
Multiple alternative splicing markers for ovarian cancerRoscoe Klinck, Anne Bramard, Lyna Inkel, et al.
Mayo Clinic Proceedings|June 15, 2006
Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trialKostandinos Sideras, Paul L Schaefer, Scott H Okuno, et al.
Annals of Neurology|November 13, 2007
Chemical chaperone therapy: clinical effect in murine G(M1)-gangliosidosisYoshiyuki Suzuki, Satoshi Ichinomiya, Mieko Kurosawa, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2001
The design of phenylglycine containing benzamidine carboxamides as potent and selective inhibitors of factor XaS D Jones, J W Liebeschuetz, P J Morgan, et al.
Current Environmental Health Reports|October 16, 2023
Air Pollution and Temperature: a Systematic Review of Ubiquitous Environmental Exposures and Sudden Cardiac DeathWilliam Borchert, Stephanie T Grady, Jie Chen, et al.
Nucleic Acids Research|March 21, 2019
Enhanced Cas12a editing in mammalian cells and zebrafishPengpeng Liu, Kevin Luk, Masahiro Shin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2010
Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741Howard L McLeod, Daniel J Sargent, Sharon Marsh, et al.
Pageof 119